Moelis & Company (MC) Q1 2026 earnings review
Record First Quarter Revenue Masks Severe Growth Deceleration
Moelis delivered a Q1 revenue record of $319.8M, but beneath the headline, the core growth engine is stalling. Revenue growth decelerated violently to just 4% YoY, a massive drop from the 41% growth seen a year ago and a steep sequential drop from a blistering 25Q4. Earnings optics look terrible—Adjusted EPS plummeted 22% to $0.50—though this is heavily distorted by a tough prior-year tax comparison. Stripping away the tax noise, Adjusted Pre-tax income actually grew 11%. Still, surging non-compensation expenses (+16% YoY) are eating into operating leverage. Management points to a pipeline 'near all-time highs,' but the hard data shows a business losing its top-line momentum while cost pressures mount.
🐂 Bull Case
Despite top-line stagnation, Adjusted Pre-tax margin expanded to 15.0% from 14.0% a year ago, driven by disciplined management of the compensation ratio (down to 65.8% from 69.0%).
The firm is successfully executing its growth strategy, locking in 8 new Managing Directors (2 already joined, 6 committed), positioning it to capture market share across Private Capital Advisory, Capital Markets, and Energy.
🐻 Bear Case
The 4% revenue growth is a stark deceleration. Moelis is facing tougher YoY comparisons, and sequential revenue dropped by over $168M from 25Q4 to 26Q1.
Adjusted non-comp expenses spiked 16% YoY to $67.2M, driven by higher deal-related costs and technology spend. This non-comp ratio hit 21%, heavily reversing the operating leverage gained in the back half of 2025.
⚖️ Verdict: 🔴
Bearish. While pre-tax margins held up due to lower compensation accruals, a 4% top-line growth rate paired with a 16% jump in non-comp costs does not support the 'all-time high pipeline' narrative. The business is decelerating.
Key Themes
Violent Deceleration in Top-Line Growth
Moelis's YoY revenue growth rate has been on a persistent downward slide, dropping from 41% in 25Q1 to 38% -> 34% -> 11%, and now finally crashing to just 4% in 26Q1. While management correctly cites 'record first quarter revenues,' the trajectory is alarming and suggests the recent M&A recovery cycle may already be fully priced in or losing steam.
Non-Compensation Expenses Squeeze Operating Leverage
While Moelis successfully dialed back its compensation ratio to 65.8% (from 69.0% a year ago), that benefit was severely diluted by surging overhead. Adjusted non-compensation expenses grew 16% YoY to $67.2M, pushing the non-comp ratio up to 21.0% of revenue. Management blamed 'deal-related costs' and 'communications and technology expenses.'
Bottom Line Distorted by Tax Comparisons
A casual glance at the income statement shows Net Income plunging 21% YoY. However, this is an optical illusion created by tax timing. 25Q1 included a massive tax benefit from the settlement of share-based awards ($11.4M benefit). In 26Q1, the tax provision normalized to an expense of $4.8M. Adjusted Income Before Taxes actually grew 11% YoY, reflecting true underlying operational stability.
M&A and Private Capital Advisory Act as Growth Pillars
The modest 4% revenue growth was driven entirely by M&A and Private Capital Advisory (PCA), which offset notable declines in Capital Structure Advisory and Capital Markets. This validates the firm's heavy strategic investments over the last year to build PCA into a 'fourth pillar' of the firm, successfully hedging against cyclical weakness in restructuring.
Aggressive Talent Acquisition Continues
Moelis is using its debt-free balance sheet to opportunistically poach talent. The firm added two Managing Directors (focused on private credit secondaries and Healthcare) and committed to hiring six more throughout the year, targeting London (Chemicals/Sponsors), Energy, and Private Capital Advisory.
Other KPIs
Reversing. Cash dropped precipitously from $848.8M at the end of 2025 down to $353.7M. This extreme sequential cash burn is primarily driven by seasonal bonus payouts, compounded by massive capital returns: the firm repurchased 1.9M shares for $117.3M and paid out dividends, returning a total of $171.4M to shareholders in the quarter alone. The balance sheet remains debt-free.
Accelerating aggressively. Moelis bought back 1.9M shares in a single quarter (including a quarterly record 0.9M open market repurchases at $59.78/share, plus 1.0M to settle tax liabilities). For context, the firm repurchased just 0.9M shares in the entire full year of 2025. Management is clearly executing heavily against their newly authorized $300M repurchase program.
Guidance
Stable. The board maintained the regular quarterly dividend at $0.65, demonstrating confidence in baseline cash generation despite the sequential revenue drop.
Key Questions
M&A Conversion Timelines
You highlight that the pipeline is 'near all-time highs,' yet Q1 revenue grew only 4% YoY and fell sharply sequentially. Is the conversion cycle from pipeline to recognized revenue stretching out, and are delayed closings becoming a structural issue?
Non-Compensation Expense Trajectory
Adjusted non-comp expenses spiked to 21% of revenue in Q1. How much of this is related to fixed technology investments versus variable deal-related costs, and what is a normalized run-rate for the rest of 2026?
Capital Structure Advisory Weakness
With Capital Structure Advisory declining in Q1, do you view the liability management and restructuring cycle as officially winding down, or is this just a temporary lull due to open capital markets?